Foundations Atlanta Outpatient) Drug Alcohol Substance Addiction Rehab Treatment Center

Published February 8, 2014

Foundations Atlanta Outpatient) Drug Alcohol Substance Addiction Rehab Treatment Center —

Small Atlanta biomed firm Phigenix suing Genentech over patent
Donald referred questions to his lawyers. The Genentech cancer drug at the center of the controversy, Kadcyla, costs about $ 117,600 for a year's treatment, according to published reports. Genentech is a subsidiary of the Swiss drug giant Roche Holding AG.
Read more on Atlanta Journal Constitution

Hoffman among thousands of addiction victims
An admitted drug addict who first sought professional help more than two decades ago, Hoffman apparently succumbed to his illness with an overdose despite a return to rehab last March. A father of three with a thriving career, the Oscar winner died …
Read more on WGCL Atlanta

Related Drug Treatment Centers Atlanta Information…